Synthesis, DNA-binding and cytotoxic properties of a bis(netropsin)-anthracenedione conjugate

Anti-Cancer Drug Design

Volumn 12, Issue 6, 1997, Pages 481-501

  Boitte, Nezha ^a   Pommery, Nicole ^a   Colson, Pierre ^b   Houssier, Claude ^b   Waring, Michael J ^c   Hénichart, Jean Pierre ^a   Bailly, Christian ^d  

^a Institut de Chimie Pharmaceutique   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CENTRE OSCAR LAMBRET   (France)

Author keywords

Anticancer drug; DNA binding; Mitoxantrone; Netropsin

Indexed keywords

ANTINEOPLASTIC AGENT; BIS(NETROPSIN) ANTHRACENEDIONE CONJUGATE; CONGOCIDINE; CONGOCIDINE DERIVATIVE; DNA TOPOISOMERASE (ATP HYDROLYSING); MITOXANTRONE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN MCF 7; CIRCULAR DICHROISM; CONTROLLED STUDY; DNA CLEAVAGE; DNA FOOTPRINTING; DNA HELIX; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; LINEAR DICHROISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL DIVISION; DNA FOOTPRINTING; DNA TOPOISOMERASES, TYPE II; DNA, NEOPLASM; HUMANS; MICE; MITOXANTRONE; MOLECULAR SEQUENCE DATA; NETROPSIN; SPECTRUM ANALYSIS; TUMOR CELLS, CULTURED; VISCOSITY;

MURINAE;

EID: 0030876395     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. AGBANDJE, M., JENKINS, TC, McKENNA, R., RESZKA, A.p & NEIDLE, S. (1992). Anthracene-9, 10-diones as potential anticancer agents. Synthesis, DNA-binding and biological studies on a series of 2,6-disubstituted derivatives. Journal of Medicinal Chemistry, 35, 1418.
2. BAILLY, C. (1997). Sequence-specific recognition and modification of double-helical DNA by minor groove binding conjugates structurally related to netropsin and distamycin. In Advances in DNA Sequence Specific Agents, Vol. 3. Palumbo, M. (ed.). JAI Press, in press.
3. BAILLY, C & HENICHART, J.P. (1991), DNA recognition by intercalator-minor groove binder hybrid molecules. Bioconjugate Chemistry, 2, 379.
4. BAILLY, C. & HENICHART, J P (1994). Molecular pharmacology of intercalator-minor groove binder hybrid groove binder hybrid molecules. In Molecular Aspects of Anticancer Drug-DNA Interactions, Vol. 2. Neidle, S. & Waring, M.J. (eds), p. 162. Macmillan: London.
5. BAILLY, C. & WARING, M.J. (1995a). Comparison of different footprinting methodologies for detecting binding sites for a small ligand on DNA. Journal of Biomolecular Structure and Dynamics, 12, 869.
6. BAILLY, C. & WARING, M.J. (1995b). Transferring the purine 2-amino group from guanines to adenines in DNA changes the sequence-specific binding of antibiotics. Nucleic Acids Research, 23, 885.
7. BAILLY, C., POMMERY, N., HOUSSIN, R. & HENICHART, JP. (1989). Design, synthesis, DNA-binding and biological activity of a series of DNA minor groove binding intercalating drugs. Journal of Pharmaceutical Sciences, 78, 910.
8. BAILLY, C., HELBECQUE, N., HENICHART, JP, COLSON, P., HOUSSIER, C., RAO, K.E , SHEA, R.G. & LOWN, J.W. (1990). Molecular recognition between oligopeptides and nucleic acids. DNA sequence specificity and binding properties of an acridine-linked netropsin hybrid ligand. Journal of Molecular Recognition, 3, 26.
9. BAILLY, C., HENICHART, JP., COLSON, P. & HOUSSIER, C (1992). Drug-DNA sequence-dependent interactions analysed by electric linear dichroism. Journal of Molecular Recognition, 5, 155.
10. BAILLY, C, ROUTIER, S., BERNIER, J.L. & WARING, M J. (1996a). DNA recognition by two mitoxantrone analogues: influence of the hydroxyl groups. FEBS Letters, 379, 269.
11. BAILLY, C., PAYET, D., TRAVERS, A.A. & WARING, MJ (1996b). PCR-based development of DNA substrates containing modified bases: an efficient system for investigating the role of the exocyclic groups in chemical and structural recognition by minor groove binding drugs and proteins. Proceedings of the National Academy of Sciences, USA, 93, 13623.
12. BOURDOUXHE, C., COLSON, P, HOUSSIER, C , SUN, J.S., MONTENAY-GARESTIER, T., HELENE, C , RIVALLE, C., BISAGNI, E., WARING, M.J., HENICHART, J.P. & BAILLY, C. (1992). Binding of a distamycin-ellipticine hybrid molecule to DNA and chromatin: spectroscopic, biochemical and molecular modeling investigations. Biochemistry, 31, 12385.
13. BOURDOUXHE, C., COLSON, P., HOUSSIER, C, HENICHART, J.P., WARING, M J., DENNY, W.A. & BAILLY, C. (1995). Design of composite drug molecules: mutual effects on binding to DNA of an intercalator, amsacrine, and a minor groove binder, netropsin. Anti-Cancer Drug Design, 10, 131.
14. CAPRANICO, G. & ZUNINO, F. (1995). Antitumor inhibitors of DNA topoisomerases. Current Pharmaceutical Design, 1, 1.
15. COLLIER, D.A & NEIDLE, S. (1988). Synthesis, molecular modeling, DNA binding and antitumor properties of some substituted amidoanthraquinones. Journal of Medicinal Chemistry, 31, 847.
16. COLSON, P., BAILLY, C. & HOUSSIER, C. (1996). Electric linear dichroism as a new tool to study sequence preference in drug binding to DNA. Biophysical Chemistry, 58, 125.
17. DE ISABELLA, P, PALUMBO, M., SISSI, C., CAPRANICO, G , CARENINI, N., MENTA, E., OLIVA, A., SPINELLI, S , KRAPCHO, A P., GIULIANI, F.C. & ZUNINO, F (1995). Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxideanthracenedione derivatives. Molecular Pharmacology, 30, 30.
18. FOX, K R , WARING, M.J., BROWN, J.R. & NEIDLE, S. (1986). DNA sequence preferences for anti-cancer drug mitoxantrone and related anthraquinones revealed by DNase I footprinting. FEBS Letters, 202, 289.
19. FOX, M.E. & SMITH, P.J. (1990). Long term inhibition of DNA synthesis and the persistence of trapped topoisomerase II complexes in determining the toxicity of the antitumor DNA intercalators m-AMSA and mitoxantrone. Cancer Research, 50, 5813.
20. GATTO, B., ZAGOTTO, G., SISSI, C., CERA, C., URIARTE, E , PALU, G , CAPRANICO, G. & PALUMBO, M (1996). Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. Journal of Medicinal Chemistry, 39, 3114.
21. GRANT, R.C, HARWOOD, S J & WELLS, R.D. (1968). The synthesis and characterization of poly d(I-C)•poly d(I-C). Journal of the American Chemical Society, 90, 4474.
22. HAZLEHURST, L.A., KRAPCHO, A.P. & HACKER, M.P. (1995). Correlation of DNA reactivity and cytotoxicity of a new class of anticancer agents: aza-anthracenediones. Cancer Letters, 91, 115.
23. HENICHART, J P., WARING, M.J., RIOU, J F., DENNY, WA & BAILLA, C. (1997). Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin-amsacrine combilexin. Molecular Pharmacology, 51, 448.
24. HOUSSIER, C. (1981). Investigating nucleic acids, nucleoproteins, polynucleotides, and their interactions with small ligands by electro-optical systems. In Molecular Electro-Optics. Krause, S. (ed.), p. 363. Plenum Publishing Corporation: New York.
25. HOUSSIER, C. & O'KONSKI, C.T. (1981). Electro-optical instrumentation systems with their data acquisition and treatment. In Molecular Electro-Optics. Krause, S. (ed.), p. 309. Plenum Publishing Corporation: New York.
26. ISLAM, S.A., NEIDLE, S., GANDECHA, B.M., PARTRIDGE, M., PATTERSON, L.H & BROWN. J.R. (1985). Comparative computer graphics and solution studies of the DNA interaction of substituted anthraquinones based on doxorubicin and mitoxantrone. Journal of Medicinal Chemistry, 28, 857.
27. KAPUSCINSKI, J., DARZYNKIEWICZ, Z, TRAGANOS, F. & MELAMED, M.R. (1981). Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10- anthracenedione, with nucleic acids. Biochemical Pharmacology, 30, 231.
28. 2. Journal of Biomolecular Structure and Dynamics, 4, 111.
29. KRAPCHO, A.P., LANDI, J.J., HACKER, M.P. & MCCORMACK, J.J. (1985). Synthesis and antineoplastic evaluation of 5,8-bis[(aminoalkyl)amino]-1-aza-anthracene-9,10-diones. Journal of Medicinal Chemistry, 28, 1124.
30. KRAPCHO, A.P., GETAHUN, Z., AVERY, K.L JR, VARGAS, K.J., HACKER, M.P., SPINELLI, S., PEZZONI, G. & MANZOTTI, C. (1991). Synthesis and antitumor evaluation of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalky1)amino]anthracene-9,10-diones and 1,4-bis[(aminoalky1)amino]-5,8-dihydroxyanthracene-9,10-diones: synthesis and antitumor evaluations. Journal of Medicinal Chemistry, 34, 2373.
31. KRAPCHO, A.P., MARESCH, M.J., HACKER, M.P., HAZELHURST, L., MENTA, E., OLIVA, A., SPINELLI S., BEGGIOLIN, G., GIULIANI, F.C., PEZZONI, G & TOGNELLA, S. (1995). Anthracene-9,10-diones and aza bioisosteres as antitumor agents. Current Medicinal Chemistry, 2, 803.
32. LOWN, J.W., MORGAN, A R., YEN, S.-F., WANG, Y.-H. & WILSON, W.D. (1985). Characteristics of the binding of the anticancer agents mitoxantrone and amenantrone and related structures to deoxyribonucleic acids. Biochemistry, 24, 4028.
33. MANIATIS, T., FRITSCH, E.F. & SAMBROOK, J. (1982). Molecular Cloning, a Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
34. MEIKLE, I., CUMMINGS, J., MCPHERSON, J.S., HADFIELD, JA & SMYTH, J.F. (1995a). Biochemistry of topoisomerase I and II inhibition by anthracenyl-amino acid conjugates. Biochemical Pharmacology, 49, 1747.
35. MEIKLE, I., CUMMINGS, J., MCPHERSON, J.S & SMYTH, J.F. (1995b). Identification of anthracenyl-dipeptide conjugates as novel topoisomerase I and II inhibitors and their evaluation as potential anticancer agents. Anti-Cancer Drug Design, 10, 515.
36. MORIER-TEISSIER, E., BERNIER, J.L, LOHEZ. M., CATTEAU, J.P. & HENICHART, J.P. (1990). Free radical production and DNA cleavage by copper chelating peptide-anthraquinones. Anti-Cancer Drug Design, 5, 291.
37. MORIER-TEISSIER, E., BOITTE, N., HELBECQUE, N., BERNIER, J L., POMMERY, N., DUVALET, J L, FOURNIER, C., HECQUET, B., CATTEAU, J.R & HENICHART, J P. (1993). Synthesis and antitumor properties of an anthraquinone bisubstituted by the copper chelating peptide Gly-Gly-L-His. Journal of Medicinal Chemistry, 36, 2084.
38. PALU, G., PALUMBO, M., ANTONELLO, C., MELONI, G.A. & MARCIANI-MAGNO, S. (1986). A Search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives. Molecular Pharmacology, 29, 211.
39. PALUMBO, M. & GATTO, B. (1990). Aminoacyl-anthraquinones: DNA-binding and sequence specificity. In Molecular Basis of Specificity in Nucleic Acid-Drug Interactions. Pullman, B. & Jortner, J. (eds), p. 207.
40. PALUMBO, M., PALU, G., GIA, O., FERRAZZI, E, GASTALDI, S., ANTONELLO, C & MELONI, GA. (1987). Bis-substituted hydroxy-anthracenediones: DNA binding and biological activity. Anti-Cancer Drug Design, 1, 337.
41. PANOUSIS, C. & PHILLIPS, D.R. (1994). DNA sequence specificity of mitoxantrone. Nucleic Acids Research, 22, 1342.
42. PANOUSIS, C, KETTLE, A.J & PHILLIPS, D.R. (1994). Oxidative metabolism of mitoxantrone by the human neutrophil enzyme myeloperoxidase. Biochemical Pharmacology, 48, 2223.
43. PANOUSIS, C., KETTLE, A.J. & PHILLIPS, DR (1995). Myeloperoxidase oxidizes mitoxantrone to metabolites which bind covalently to DNA and RNA. Anti-Cancer Drug Design, 10, 593.
44. PARKS, M.E., BAIRD, E. E. & DERVAN, P.B. (1996a). Optimization of the hairpin polyamide design for recognition of the minor groove of DNA. Journal of the American Chemical Society, 118, 6147.
45. 2-3′ sequences in the minor groove of DNA by hairpin polyamides. Journal of the American Chemical Society, 118, 6153.
46. PORTUGAL, J & WARING, M.J. (1987). Comparison of binding sites in DNA for berenil, netropsin and distamycin. A footprinting study. European Journal of Biochemistry, 167, 281.
47. RESZKA, K., KOLODZIEJCZYK, P., HARTLEY, J.A., WILSON, W.D. & LOWN, JW. (1988). Molecular pharmacology of anthracenedione-based anticancer agents. In Bioactive Molecules. Lown, J.W (ed.), Vol. 6, p. 401. Elsevier: Amsterdam.
48. ROUTIER, S., COTELLE, N, CATTEAU, J.P., BERNIER, JL, WARING, M J., RIOU, JF. & BAILLY, C. (1996). Salen-anthraquinone conjugates. Synthesis, DNA-binding and cleaving properties, effects on topoisomerases and cytotoxicity. Bio Organic and Medicinal Chemistry, 4, 1185.
49. TAKEUCHI, N., NAKAMURA, T, TAKEUCHI, F., HASHIMOTO, E. & YAMAMURA, H (1992). Inhibitory effect of mitoxantrone on activity of protein kinase C and growth of HL60 cells. Biochemical Journal, 112, 762.
50. WANG, J.C. (1974). The degree of unwinding of the DNA helix by ethidium. Journal of Molecular Biology, 89, 783.
51. WARING, M.J. & HENLEY, S.M. (1975). Stereochemical aspects of the interaction between steroidal diamines and DNA. Nucleic Acids Research, 2, 567.
52. WELLS, R.D., LARSON, J.E., GRANT, R.C , SHORTLE, BE & CANTOR, C.R. (1970). Physicochemical Studies on polydeoxyribonucleotides containing defined repeating nucleotide sequences. Journal of Molecular Biology, 54, 465.